Calculator Template

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: (insert your name here)

Synonyms and keywords: (add synonyms and create redirects)

Overview

[Name of the Score] is a (± validated) risk assessment tool designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other endpoints) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other conditions).

[Name of the Score]

Historical Perspective

[Name of the Score] was invented by (Author) et al in (year).(references)

Purpose

[Name of the Score] is a (risk assessment tool/risk stratification scheme) designed to assess the (30-day/5-year) risk of (bleeding/ischemia/other endpoints) associated with (antiplatelet/antithrombotic/other treatment) among patients with (coronary heart disease/heart failure/other conditions).

[Name of the Score] is a (clinical prediction rule) devised to assess the severity of (acute pancreatitis/other disease) among (hospitalized patients/healthy individuals/other population) in the (outpatient/inpatient/surgical/medical/emergency room) setting.

[Name of the Score] is a (prediction model) created to estimate the (mortality/bleeding rate/pre-test probability) of (acute pulmonary embolism/other disease) among (hospitalized patients/healthy individuals/other population).

[Name of the Score] is a (decision tool) designed to assist the decision-making pertaining to the (risk/benefit) of (antiplatelet/antithrombotic/other treatment) for (acute coronary syndrome/other conditions) among (hospitalized patients/healthy individuals/other population).

Components

[Name of the Score] consists of (number) parameters including clinical variables (age/sex/weight/creatinine clearance/past history/clinical presentation), laboratory values (WBC/hemoglobin/platelet), and imaging findings (diffuse pulmonary infiltrates/prolonged QT interval).

Interpretation

• Score ≤1: low-risk (<1% mortality); no treatment or hospital admission is needed.
• Score 2–3: intermediate-risk (1 to 5% mortality); consider treatment or hospitalization.
• Score ≥4: high-risk (>5% mortality); treatment/hospitalization is needed.

Performance

[Name of the Score] demonstrates modest discrimination (c statistic 0.64 [95% CI, 0.66 to 0.88]).

Guideline Recommendations

[Name of the Score] has been included in the (ACC/AHA/ESC/ACCP) guideline recommendations for the assessment of

[Name of the Score] Calculator

Shown below is the calculator for [Name of the Score] (check all the boxes that apply):

(insert widget here)

See also

• (Relevant score 1)
• (Relevant score 2)
• (Relevant score 3)